Elizabeth Anderson CFA
Stock Analyst at Evercore ISI
(3.87)
# 1,892
Out of 5,058 analysts
610
Total ratings
52.8%
Success rate
3.9%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IQV IQVIA Holdings | Reiterated: Buy | $275 → $290 | $266.90 | +8.65% | 23 | Oct 14, 2026 | |
| HUM Humana | Reiterated: Buy | $480 | $413.16 | +16.18% | 10 | Oct 13, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $480 | $401.43 | +19.57% | 6 | Oct 13, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,000 | $1,004.84 | -0.48% | 33 | Oct 6, 2026 | |
| ALGN Align Technology | Downgraded: Hold | $220 → $155 | $147.31 | +5.22% | 47 | Oct 5, 2026 | |
| CVS CVS Health | Reiterated: Buy | $125 | $92.36 | +35.34% | 39 | Oct 2, 2026 | |
| CI The Cigna Group | Reiterated: Hold | $290 | $302.30 | -4.07% | 2 | Oct 1, 2026 | |
| DOCS Doximity | Reiterated: Hold | $40 → $35 | $30.97 | +13.01% | 33 | Sep 29, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Buy | $320 → $330 | $300.15 | +9.95% | 34 | Sep 25, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $28 | $27.36 | +2.34% | 18 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $317.95 | +6.94% | 17 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $17.63 | +41.80% | 12 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 | $340.92 | +2.66% | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.00 | +100.00% | 2 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $270 | $254.06 | +6.27% | 32 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $14 | $8.57 | +63.36% | 29 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $125 | $85.12 | +46.85% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $39 | $35.96 | +8.45% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $32 | $22.90 | +39.74% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $32 | $22.52 | +42.10% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $105 | $99.16 | +5.89% | 9 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $105 | $86.38 | +21.56% | 28 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $25 | $22.49 | +11.16% | 24 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $170.18 | +29.27% | 23 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $7.5 | $5.67 | +32.28% | 30 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $360 | $428.26 | -15.94% | 3 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $210 | $235.00 | -10.64% | 19 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.73 | +73.91% | 23 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8.5 | $0.5866 | n/a | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 → $3 | $0.3242 | n/a | 7 | May 6, 2022 |
IQVIA Holdings
Oct 14, 2026
Reiterated: Buy
Price Target: $275 → $290
Current: $266.90
Upside: +8.65%
Humana
Oct 13, 2026
Reiterated: Buy
Price Target: $480
Current: $413.16
Upside: +16.18%
UnitedHealth Group
Oct 13, 2026
Reiterated: Buy
Price Target: $480
Current: $401.43
Upside: +19.57%
McKesson
Oct 6, 2026
Reiterated: Buy
Price Target: $1,000
Current: $1,004.84
Upside: -0.48%
Align Technology
Oct 5, 2026
Downgraded: Hold
Price Target: $220 → $155
Current: $147.31
Upside: +5.22%
CVS Health
Oct 2, 2026
Reiterated: Buy
Price Target: $125
Current: $92.36
Upside: +35.34%
The Cigna Group
Oct 1, 2026
Reiterated: Hold
Price Target: $290
Current: $302.30
Upside: -4.07%
Doximity
Sep 29, 2026
Reiterated: Hold
Price Target: $40 → $35
Current: $30.97
Upside: +13.01%
Charles River Laboratories International
Sep 25, 2026
Reiterated: Buy
Price Target: $320 → $330
Current: $300.15
Upside: +9.95%
Waystar Holding
Sep 15, 2026
Reiterated: Buy
Price Target: $28
Current: $27.36
Upside: +2.34%
Sep 11, 2026
Reiterated: Buy
Price Target: $340
Current: $317.95
Upside: +6.94%
Sep 11, 2026
Reiterated: Buy
Price Target: $25
Current: $17.63
Upside: +41.80%
Aug 13, 2026
Reiterated: Buy
Price Target: $350
Current: $340.92
Upside: +2.66%
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $10.00
Upside: +100.00%
Aug 12, 2026
Reiterated: Buy
Price Target: $240 → $270
Current: $254.06
Upside: +6.27%
Aug 7, 2026
Reiterated: Hold
Price Target: $13 → $14
Current: $8.57
Upside: +63.36%
Aug 6, 2026
Reiterated: Hold
Price Target: $32 → $125
Current: $85.12
Upside: +46.85%
Aug 6, 2026
Reiterated: Buy
Price Target: $48 → $39
Current: $35.96
Upside: +8.45%
Aug 6, 2026
Reiterated: Buy
Price Target: $33 → $32
Current: $22.90
Upside: +39.74%
Aug 6, 2026
Reiterated: Buy
Price Target: $26 → $32
Current: $22.52
Upside: +42.10%
Aug 4, 2026
Reiterated: Buy
Price Target: $45 → $105
Current: $99.16
Upside: +5.89%
Aug 4, 2026
Reiterated: Buy
Price Target: $90 → $105
Current: $86.38
Upside: +21.56%
Jul 30, 2026
Reiterated: Buy
Price Target: $14 → $25
Current: $22.49
Upside: +11.16%
Jul 30, 2026
Reiterated: Buy
Price Target: $220
Current: $170.18
Upside: +29.27%
Jul 30, 2026
Reiterated: Hold
Price Target: $6 → $7.5
Current: $5.67
Upside: +32.28%
May 19, 2026
Upgraded: Buy
Price Target: $360
Current: $428.26
Upside: -15.94%
Apr 20, 2026
Reiterated: Hold
Price Target: $210
Current: $235.00
Upside: -10.64%
Mar 30, 2026
Reiterated: Hold
Price Target: $3
Current: $1.73
Upside: +73.91%
Aug 9, 2022
Reiterated: Hold
Price Target: $9 → $8.5
Current: $0.5866
Upside: n/a
May 6, 2022
Reiterated: Hold
Price Target: $2.5 → $3
Current: $0.3242
Upside: n/a